As Chief Scientific Officer, Zachary Shriver is responsible for strategic thought leadership in the areas of Research and Pharmaceutical Sciences for the company. Zachary joined Visterra in 2009 as Vice President of Research and has over 20 years of experience in the biotechnology industry. Prior to Visterra, Zachary was one of the founding scientists at Momenta Pharmaceuticals. While at Momenta, Zachary led the development of state-of-the-art analytical techniques to enable the design of several complex (polysaccharide, polypeptide, and biologics-based) products, supporting multiple INDs and NDAs. Zachary is an inventor on over 65 issued patents and has authored over 100 publications, including original research on the structure and biology of complex polysaccharides, antibody engineering, and novel, high resolution analytical techniques.
Zachary received his BA in Chemistry, summa cum laude, from Amherst College and his PhD in Applied Biosciences from MIT, where his research focused on sequencing complex polysaccharides through the integration of analytical and bioinformatics-based techniques.
